Low vs High Concentration Local Anesthesia for Hip Replacement
(HALF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two types of anesthesia for individuals undergoing hip replacement surgery. The goal is to determine if low concentration anesthesia can control pain as effectively as high concentration anesthesia, but without causing muscle weakness. Individuals scheduled for hip replacement surgery in a hospital, who do not have a history of heavy opioid use, might be suitable candidates for this trial. Participants will receive either a high or low concentration of local anesthesia (fascia iliaca compartment block) to evaluate which provides the best pain relief without affecting muscle strength. As an unphased trial, this study allows participants to contribute to important research that could enhance anesthesia options for future patients.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you are using chronic opioids or have contraindications to the study medications, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both high and low concentration local anesthetics are generally safe for pain relief in hip replacement surgeries. Studies have found that high concentration anesthetics, such as ropivacaine, effectively reduce pain but can sometimes cause muscle weakness, particularly in the quadriceps, the large muscle on the front of the thigh.
Low concentration anesthetics also demonstrate promising results. They provide effective pain relief while minimizing significant muscle weakness, allowing patients to maintain better muscle strength after surgery. Evidence from other procedures, like epidurals, suggests that low concentration anesthetics can control pain safely and effectively without causing much muscle weakness.
Overall, previous studies have used both types of local anesthetics safely, with low concentrations offering the added benefit of preserving muscle strength. This makes them a potentially safer option for those concerned about muscle weakness after surgery.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential benefits of using different concentrations of ropivacaine in fascia iliaca compartment blocks for hip replacement surgery. Unlike standard anesthesia techniques, which typically use a one-size-fits-all concentration, this trial investigates both high (0.25%) and low (0.075%) concentrations of ropivacaine to see which provides better pain relief and fewer side effects. By fine-tuning the anesthetic concentration, the goal is to optimize patient outcomes, potentially reducing recovery time and enhancing comfort post-surgery. This approach could lead to more personalized pain management strategies, aligning with the broader trend in medicine towards individualized care.
What evidence suggests that this trial's treatments could be effective for postoperative analgesia in hip replacement surgery?
This trial will compare the effects of high versus low concentration local anesthetic fascia iliaca compartment blocks (FICB) for hip replacement surgery. Research has shown that an FICB can reduce the need for opioids after surgery. However, high doses of local anesthetics may cause muscle weakness. Studies have found that lower doses can still provide effective pain relief without this side effect. This has been particularly noted in surgeries related to childbirth. Overall, lower doses might offer the same pain relief as higher doses but with fewer side effects, such as muscle weakness.14678
Who Is on the Research Team?
Hermann dos Santos Fernandes, MD, PhD
Principal Investigator
University of Toronto
Are You a Good Fit for This Trial?
This trial is for adults over 21 years old who are having a primary total hip arthroplasty (hip replacement) in an inpatient setting. They should not be pregnant, have no severe anatomical issues, infections, or allergies to the study's medications, and must not be dependent on alcohol or drugs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Operative Assessment
Participants undergo pre-anesthesia consultation and receive study information
Treatment
Participants receive either low or high concentration local anesthesia fascia iliaca block during total hip arthroplasty
Postoperative Monitoring
Participants are assessed for pain scores, quadriceps muscle weakness, and opioid consumption at multiple time points after surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- High Concentration Local Anesthetic Fascia Iliaca Compartment Block
- Low Concentration Local Anesthetic Fascia Iliaca Compartment Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Toronto
Lead Sponsor